RecruitingNCT07283185

Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis

Prospective Comparison of the Carbon Footprint of Endoscopic Ultrasound (EUS) vs Magnetic Resonance Cholangiopancreatography (MRCP) for Evaluation of Suspected Choledocholithiasis


Sponsor

Asian Institute of Gastroenterology, India

Enrollment

200 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT. However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Age ≥18 years
  • Intermediate likelihood of CBD stone (per ESGE)
  • Undergoing either MRCP or EUS for evaluation

Exclusion Criteria3

  • High or low likelihood category (per ESGE)
  • Undergoing both MRCP and EUS simultaneously
  • Contraindications to either modality

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

AIG Hospitals

Hyderabad, Telangana, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07283185


Related Trials